Based in Princeton, NJ, Biopticon is a leading developer, manufacturer, and marketer of next-generation measurement and data management systems for pre-clinical animal studies. Biopticon’s proprietary solutions give researchers performing oncology animal studies, the ability to accelerate the drug development process by improving the performance, throughput, cost effectiveness, and flexibility of their pre-clinical animal studies. A comprehensive line of products and services is offered that provides users with data that is critical to the determination of accurate results in pre-clinical testing. Customers include pharmaceutical companies, academic institutions, clinical research organizations, and biotechnology companies.